Bifogade filer
PDF
Kurs
+31,82%
Likviditet
1,36 MSEK
Kalender
| Est. tid* | ||
| 2025-11-15 | 08:50 | Kvartalsrapport 2025-Q3 |
| 2025-08-22 | - | Kvartalsrapport 2025-Q2 |
| 2025-06-17 | - | Årsstämma |
| 2025-06-12 | - | X-dag ordinarie utdelning EVOL 0.00 SEK |
| 2025-05-28 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-19 | - | Bokslutskommuniké 2024 |
| 2024-11-15 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-22 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-12 | - | X-dag ordinarie utdelning EVOL 0.00 SEK |
| 2024-06-11 | - | Årsstämma |
| 2024-05-23 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-23 | - | Bokslutskommuniké 2023 |
| 2024-01-11 | - | Extra Bolagsstämma 2023 |
| 2023-11-17 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-17 | - | Kvartalsrapport 2023-Q2 |
| 2023-07-06 | - | Split EVOL 100:1 |
| 2023-06-12 | - | X-dag ordinarie utdelning EVOL 0.00 SEK |
| 2023-06-09 | - | Årsstämma |
| 2023-05-17 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-23 | - | Bokslutskommuniké 2022 |
| 2022-12-27 | - | Extra Bolagsstämma 2022 |
| 2022-10-24 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-23 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-11 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-27 | - | X-dag ordinarie utdelning EVOL 0.00 SEK |
| 2022-04-26 | - | Årsstämma |
| 2022-02-25 | - | Bokslutskommuniké 2021 |
| 2021-11-16 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-24 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-11 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-27 | - | X-dag ordinarie utdelning EVOL 0.00 SEK |
| 2021-04-26 | - | Årsstämma |
| 2021-02-19 | - | Bokslutskommuniké 2020 |
| 2021-02-02 | - | Extra Bolagsstämma 2021 |
| 2020-11-20 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-19 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-20 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-22 | - | Extra Bolagsstämma 2020 |
| 2020-03-31 | - | X-dag ordinarie utdelning EVOL 0.00 SEK |
| 2020-03-30 | - | Årsstämma |
| 2020-02-18 | - | Bokslutskommuniké 2019 |
| 2019-11-20 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-21 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-22 | - | Kvartalsrapport 2019-Q1 |
| 2019-03-29 | - | X-dag ordinarie utdelning EVOL 0.00 SEK |
| 2019-03-28 | - | Årsstämma |
| 2019-02-15 | - | Bokslutskommuniké 2018 |
| 2018-08-16 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-03 | - | X-dag ordinarie utdelning EVOL 0.00 SEK |
| 2018-05-02 | - | Årsstämma |
| 2018-04-27 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-20 | - | Bokslutskommuniké 2017 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Stockholm - 2025-09-11
Evolear has completed the acquisition of Solution International Holdings Ltd ("Solution") in accordance with the unanimous resolutions passed at the Annual General Meeting on 17 June 2025.
The purchase price of approximately SEK 160 million is paid through two promissory notes, of which SEK 135 million will be set off against 39,705,882 newly issued shares in Evolear at a subscription price of SEK 3.40 per share, and SEK 25 million carries a three-year tenor with an annual interest rate of five (5) percent. Following registration of the set-off share issue, Solution's founder Mark McLoughlin is expected to hold approximately 89.92 percent of the Company's shares and votes. This press release also constitutes a flagging notification of a new major shareholder in accordance with the Spotlight Stock Market rulebook, as Mark McLoughlin becomes the principal shareholder.
In connection with completion, the process to change the Company's name to Solution International Holdings AB (publ) will be initiated, subject to registration with the Swedish Companies Registration Office (Bolagsverket). If the exact name cannot be registered, the Board has a mandate to determine a similar name that can be approved by Bolagsverket. The Board also intends to implement a CEO transition whereby Mark McLoughlin will be appointed Chief Executive Officer. Formal assumption of office will occur once the necessary registrations and formalities have been completed, and the transition will be communicated separately when it takes place.
About Solution
Solution is a leading provider in the design, development, manufacture and supply of innovative baby and children's products to retail, both as private-label and licensed ranges. The product portfolio includes, among other categories, feeding and bibs, bath and potty training, children's tableware, play and nursery. The company has operated in Europe since 2008. Headquarters are in Bedfordshire, United Kingdom and a European office in Boxtel, the Netherlands.
For further information, please contact:
Jesper Nord
Chief Executive Officer
Evolear AB (Publ)
ir@evolear.com